Clinical Trials in Cardiology - O

Maintained by Dr. Olga Shindler. Last update on: February 20, 2001

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

OARS
Optimal Atherectomy Restenosis Study
J Am Coll Cardiol 1998 Aug;32(2):329-37

OARS (Substudy)
Optimal Atherectomy Restenosis Study
J Am Coll Cardiol 1998 Aug;32(2):329-37

OASIS
Organization to Assess Strategies for Ischemic Syndromes
Circulation 1997; 96:769-777
Circulation 1996; 94(Suppl I):196

OASIS (Warfarin Substudy)
Organization to Assess Strategies for Ischemic Syndromes
Circulation 1998;98:1064-1070

OASIS 2
Organization to Assess Strategies for Ischemic Syndromes
Lancet 1999;353:429-438

OAT
Occluded Artery Trial

OAT
Ochanomizu Aspirin Trials

OAT
Open Artery Trial

OB43
OBjective 43, a later and parallel study to RF2
Panminerva Med 1998 Mar;40(1):55-7
Int J Epidemiol 1992 Oct;21(5):883-92

OCS
Oxford Cholesterol Study

OCSP
Oxfordshire Community Stroke Project

OCTAVE
Omapatrilat Cardiovascular Treatment Assessment Vs. Enalapril

OD1
Organ Disease 1, a multicenter study on coronary atherosclerosis by the Italian CNR

OD2
Organ Disease 2, a multicenter study on cerebrovascular atherosclerosis by the Italian CNR

ODES
Oslo Diet and Exercise Study

OIS
Oslo Ischemia Study

OPALS
Ontario Prehospital Advanced Life Support
JAMA 1999;281:1175-1181

OPCS
Office of Population and Censuses and Surveys

OPERA
Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events

OPTICUS
OPTimization with ICUS to reduce stent restenosis
Am Heart J 1999;137:555-574

OPTIMAAL
OPtimal Trial In Myocardial infarction with the Angiotensin II Antagonist Losartan
Am J Cardiol 1999;83:477-481


Optimal Oral anticoagulant Therapy In patients with Mechanical heart valves
N Engl J Med 1995;333:11-17

OPTIME-CHF
Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure

OPUS
Optimal angioplasty and primary stenting

OPUS-Timi 16
Orbofiban in Patients with Unstable coronary Syndromes
(a) Circulation 2000 Jul 11;102(2):149-56
(b) Clin Cardiol 2000 Nov;23 Suppl 6:VI-14-7

OPUS-TIMI 16
Orbofiban in Patients with Unstable coronary Syndromes, Thrombolysis In Myocardial Infarction 16
Am J Cardiol 2000 Feb 15;85(4):491-3, A10

ORBIT
Oral glycoprotein IIb/IIIa Receptor Blockade to Inhibit Thrombosis
Circulation 1998;98:1268-1278

ORLS
Oxford Record Linkage Study

OSACA
Osaka follow-up Study for ultrasonographic Assessment of Carotid Atherosclerosis

OSCAR
Olive oil Safflower oil Canola oil And Rapeseed oil dietary study

OSDAT
Oslo Study Diet & Antismoking Trial
(A) Am J Med 1986 Feb 14;80(2A):7-11
(B) Prev Med 1985 May;14(3):279-92

OSIRIS
Optimization Study of Infarct Reperfusion Investigated by ST-monitoring

OST
Ottawa Stroke Trials
J Thromb Thrombolysis 1999 Jan;7(1):21-6

OURS
Oxford University Research Study

OURS
Oxygen Utilization Rate Study

OVERTURE
Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events

OXCHECK
OXford and Collaborators HEalth ChecK trial
Health Rep 1994;6(1):160-5

OYS
Oslo Youth Study
(a) Addiction, 90, 561-569
(b) Prevent.Med.1988;17:12-24,
(c) Am J Epidemiol. 1985;122:750-761
(d) Preventive Medicine 1984; 13:256-275

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

e-mail:shindler@umdnj.edu
Copyright © 1995-2001 Dr. Olga Shindler